(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-guanidinopentanoyl]amino]propanoyl]amino]-5-guanidinopentanoyl]amino]-N-[(1S)-1-[[(1S)-5-amino-1-[[(1S)-5-amino-1-[[(1S)-1-[[(1S,2R)-1-carbamoyl-2-hydroxypropyl]carbamoyl]-4-guanidinobutyl]carbamoyl]pentyl]carbamoyl]pentyl]carbamoyl]-4-guanidinobutyl]butanediamide

ID: ALA4785628

Chembl Id: CHEMBL4785628

PubChem CID: 162668070

Max Phase: Preclinical

Molecular Formula: C49H95N25O12

Molecular Weight: 1226.46

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@@H](C)O

Standard InChI:  InChI=1S/C49H95N25O12/c1-25(66-39(80)28(67-27(3)76)14-8-20-62-46(54)55)38(79)68-31(15-9-21-63-47(56)57)43(84)73-34(24-35(52)77)45(86)72-32(16-10-22-64-48(58)59)42(83)70-29(12-4-6-18-50)40(81)69-30(13-5-7-19-51)41(82)71-33(17-11-23-65-49(60)61)44(85)74-36(26(2)75)37(53)78/h25-26,28-34,36,75H,4-24,50-51H2,1-3H3,(H2,52,77)(H2,53,78)(H,66,80)(H,67,76)(H,68,79)(H,69,81)(H,70,83)(H,71,82)(H,72,86)(H,73,84)(H,74,85)(H4,54,55,62)(H4,56,57,63)(H4,58,59,64)(H4,60,61,65)/t25-,26+,28-,29-,30-,31-,32-,33-,34-,36-/m0/s1

Standard InChI Key:  IJIHRTZHINQMRH-UXTPEBOCSA-N

Alternative Forms

1. Parent:

   

   ALA4785628

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1226.46

Molecular Weight (Monoisotopic): 1225.7592

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Lewandowska-Goch MA,Kwiatkowska A,Łepek T,Ly K,Navals P,Gagnon H,Dory YL,Prahl A,Day R.  (2021)  Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin.,  12  (3): [PMID:33738063] [10.1021/acsmedchemlett.0c00386]

Source

Source(1):

• Scientific Literature